Table 2.
Top 20 KEGG pathways.
| Pathway | Pvalue | Qvalue |
|---|---|---|
| Cytokine-cytokine receptor interaction | 5.63E-36 | 1.24E-33 |
| Chemokine signaling pathway | 3.77E-14 | 4.17E-12 |
| Hematopoietic cell lineage | 5.29E-09 | 3.90E-07 |
| IL-17 signaling pathway | 1.64E-07 | 9.04E-06 |
| Protein digestion and absorption | 2.82E-06 | 1.25E-04 |
| Amoebiasis | 5.05E-06 | 1.86E-04 |
| Rheumatoid arthritis | 6.33E-06 | 2.00E-04 |
| Prion diseases | 2.71E-05 | 7.48E-04 |
| PI3K-Akt signaling pathway | 4.23E-05 | 9.42E-04 |
| Malaria | 4.60E-05 | 9.42E-04 |
| Complement and coagulation cascades | 4.69E-05 | 9.42E-04 |
| TNF signaling pathway | 5.33E-05 | 9.82E-04 |
| Pertussis | 0.00013267 | 2.26E-03 |
| AGE-RAGE signaling pathway in diabetic complications | 0.00022641 | 3.57E-03 |
| B cell receptor signaling pathway | 0.000475706 | 7.01E-03 |
| Jak-STAT signaling pathway | 0.000744929 | 1.03E-02 |
| ECM-receptor interaction | 0.000957602 | 1.24E-02 |
| Primary immunodeficiency | 0.001236546 | 1.49E-02 |
| Relaxin signaling pathway | 0.001282748 | 1.49E-02 |
| NF-kappa B signaling pathway | 0.002089419 | 2.31E-02 |